Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 571-578

  Yoshimine, Kosei ^a   Horiuchi, Masahisa ^a   Suzuki, Syusaku ^a   Kobayashi, Keiko ^a   Abdul, Jalil Md ^a   Masuda, Mina ^a   Tomomura, Mineko ^a   Ogawa, Yoshihiro ^b   Itoh, Hiroshi ^b   Nakao, Kazuwa ^b   Osame, Mituhiro ^a   Saheki, Takeyori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Animal model; Atrial natriuretic peptide; Cardiac hypertrophy; Carnitine deficiency; JVS mice; Myosin heavy chain; actin

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; CARNITINE; CONTRACTILE PROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART ATRIUM; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STEATOSIS;

EID: 0031079755     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0300     Document Type: Article

References (47)

1. ALONSO S, MINTY A, BOURLET Y, BUCKINGHAM M, 1986. Comparison of three actin-coding sequences in the mouse: evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 23: 11-22.
2. BISHOPRIC NH, JAYASENA V, WEBSTER KA, 1992. Positive regulation of the skeletal α-actin gene by Fos and Jun in cardiac myocytes. J Biol Chem 267: 25535-25540.
3. BLOCK KD, SEIDMAN JG, NAFTILAN JD, FALLON JT, SEIDMAN CE, 1986. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell 47: 695-702.
4. BRENINGSTALL GN, 1990. Carnitine deficiency syndromes. Pediatr Neurol 6: 75-81.
5. CHALLONER DR, PROLS HG, 1972. Free fatty acid oxidation and carnitine levels in diphtheritic guinea pig myocardium. J Clin Invest 51: 2071-2076.
6. CHIEN KR, KNOWLTON KU, ZHU H, CHIEN S, 1991. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 5: 3037-3046.
7. CHOMCZYNSKI P, SACCHI N, 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
8. DORN GW II, ROBBINS J, BALL N, WALSH RA, 1994. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol 267: H400-H405.
9. EL ALAOUI-TALIBI Z, LANDORMY S, LOIREAU A, MORAVEC J, 1992. Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol 262: H1068-H1074.
10. GUSTAFSON TA, MARKHAM BE, MORKIN E, 1985. Analysis of thyroid hormone effects on myosin heavy chain gene expression in cardiac and soleus muscles using a novel dot-blot mRNA assay. Biochem Biophys Res Commun 130: 1161-1167.
11. o mice. Mouse Genome 86: 261.
12. HORIUCHI M, KOBAYASHI K, TOMOMURA M, KUWAJIMA M, IMAMURA Y, KOIZUMI T, NIKAIDO H, HAYAKAWA J, SAHEKI T, 1992. Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J Biol Chem 267: 5032-5035.
13. HORIUCHI M, YOSHIDA H, KOBAYASHI K, KURIWAKI K, YOSHIMINE K, TOMOMURA M, KOIZUMI T, NIKAIDO H, HAYAKAWA J, KUWAJIMA M, SAHEKI T, 1993. Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326: 267-271.
14. HORIUCHI M, KOBAYASHI K, YAMAGUCHI S, SHIMIZU N, KOIZUMI T, NIKAIDO H, HAYAKAWA J, KUWAJIMA M, SAHEKI T, 1994. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim Biophys Acta 1226: 25-30.
15. HOTTA K, KUWAJIMA M, ONO A, UENAKA R, NAKAJIMA H, MIYAGAWA J, NAMBA M, HANAFUSA T, HORIUCHI M, NIKAIDO H, HAYAKAWA J, KONO N, SAHEKI T, MATSUZAWA Y, 1996. Altered expression of carnitine palmitoyltransferase II in liver, muscle, and heart of mouse strain with juvenile visceral steatosis. Biochim Biophys Acta 1289: 131-135.
16. o mice with juvenile steatosis of viscera. FEBS Lett 260: 119-121.
17. IZUMO S, LOMPRÉ A-M, MATSUOKA R, KOREN G, SCHWARTZ K, NADAL-GINARD B, MAHDAVI V, 1987. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 79: 970-977.
18. IZUMO S, NADAL-GINARD B, MAHDAVI V, 1988. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339-343.
19. KANDA T, NAKANO M, ARAI M, YAMAMOTO A, SUZUKI T, MURATA K, 1993. Myocardial atrial natriuretic factor gene expression after coronary ligation in rats. Exp Clin Endocrinol 101: 173-177.
20. o strain of mouse with similarities to Reye's syndrome. Lab Anim 22: 83-87.
21. KOVACIC-MILIVOJEVIC B, GARDNER DG, 1993. Regulation of the human atrial natriuretic peptide gene in atrial cardiocytes by the transcription factor AP-1. Am J Hypertens 6: 258-263.
22. KURIYAMA M, YOSHIDA H, SUZUKI M, FUJIYAMA J, IGATA A, 1990. Lysosomal acid lipase deficiency in rats: lipid analyses and lipase activities in liver and spleen. J Lipid Res 31: 1605-1612.
23. o strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun 174: 1090-1094.
24. LANSON NA JR, GLEMBOTSKI CC, STEINHELPER ME, FIELD LJ, CLAYCOMB WC, 1992. Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes. Circulation 85: 1835-1841.
25. MCBRIDE K, ROBITAILLE L, TREMBLAY S, ARGENTIN S, NEMER M, 1993. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element. Mol Cell Biol 13: 600-612.
26. MIYAGAWA J, KUWAJIMA M, HANAFUSA T, OZAKI K, FUJIMURA H, ONO A, UENAKA R, NARAMA I, OUE T, YAMAMOTO K, KAIDOH M, NIKAIDO H, HAYAKAWA J, HORIUCHI M, SAHEKI T, MATSUZAWA Y 1995. Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency. Virchows Arch 426: 271-279.
27. MUUS J, WEISS S, HASTINGS AB, 1939. Tissue metabolism in vitamin deficiencies. J Biol Chem 129: 303-307.
28. OGAWA Y, NAKAO K, MUKOYAMA M, HOSODA K, SHIRAKAMI G, ARAI H, SAITO Y, SUGA S, JOUGASAKI M, IMURA H, 1991. Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. Circ Res 69: 491-500.
29. OLSON RE, PEARSON OH, MILLER ON, STARE FJ, 1948. The effect of vitamin deficiencies upon the metabolism of cardiac muscle in vitro. J Biol Chem 175: 489-501.
30. ROBBINS J, GULICK J, SANCHEZ A, HOWLES P, DOETSCHMAN T, 1990. Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J Biol Chem 265: 11905-11909.
31. ROCKMAN HA, ROSS RS, HARRIS AN, KNOWLTON KU, STEINHELPER ME, FIELD LJ, ROSS J JR, CHIEN KR, 1991. Segregation of atrial-speciflc and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88: 8277-8281.
32. ROCKMAN HA, WACHHORST SP, MAO L, ROSS J JR, 1994. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 266: H2468-H2475.
33. ROSENZWEIG A, SEIDMAN CE, 1991. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 60: 229-255.
34. RUPP H, ELIMBAN V, DHALLA NS, 1992. Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor. FASEB J 6: 2349-2353.
35. SCHOLTE HR, PEREIRA RR, DE JONGE PC, LUYT-HOUWEN IEM, VERDUIN MHM, ROSS JD, 1990. Primary carnitine deficiency. J Clin Chem Clin Biochem 28: 351-357.
36. STANLEY CA, DELEEUW S, COATES PM, VIANEY-LIAUD C, DIVRY P, BONNEFONT J-P, SAUDUBRAY J-M, HAYMOND M, TREFZ FK, BRENINGSTALL GN, WAPPNER RS, BYRD DJ, SANSARICO C, TEIN I, GROVER W, VALLE D, RUTLEDGE SL, TREEM WR, 1991. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 30: 709-716.
37. TEIN I, DE VIVO DC, BIERMAN F, PULVER P, DE MEIRLEIR LJ, CVITANOVICSOJAT L, PAGON RA, BERTINI E, DIONISIVICI C, SERVIDEI S, DIMAURO S, 1990. Impaired skin fibroblast cartinine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 28: 247-255.
38. TOKUNAGA K, NAKAMURA Y, SAKATA K, FUJIMORI K, OHKUBO M, SAWADA K, SAKIYAMA S, 1987. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 47: 5616-5619.
39. TOMOMURA M, IMAMURA Y, HORIUCHI M, KOIZUMI T, NIKAIDO H, HAYAKAWA J, SAHEKI T, 1992a. Abnormal expression of urea cycle enzyme genes in juvenile visceral steatosis (jvs) mice. Biochim Biophys Acta 1138: 167-171.
40. TOMOMURA M, NAKAGAWA K, SAHEKI T, 1992b. Protooncogene c-jun and c-fos messenger RNAs increase in the liver of carnitine-deflcient visceral steatosis (jvs) mice. FEBS Lett 311: 63-66.
41. TOMOMURA M, IMAMURA Y, TOMOMURA A, HORIUCHI M, SAHEKI T, 1994. Abnormal gene expression and regulation in the liver of jvs mice with systemic carnitine deficiency. Biochim Biophys Acta 1226: 307-314.
42. TREEM WR, STANLEY CA, FINEGOLD DN, HALE DE, COATES PM, 1988. Primary carnitine deficiency due to failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med 319: 1331-1336.
43. TRIPP ME, KATCHER ML, PETERS HA, GILBERT EF, ARYA S, HODACH RJ, SHUG AL, 1981. Systemic carnitine deficiency presenting as familial endocardial fibromatosis. N Engl J Med 305: 385-390.
44. UENAKA R, KUWAJIMA M. ONO A, MATSUZAWA Y, HAYAKAWA J, INOHARA N, KAGAWA Y, OHTA S, 1996. Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice. J Biochem 119: 533-540.
45. UENO H, PERRYMAN MB, ROBERTS R, SCHNEIDER MD, 1988. Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol 107: 1911-1918.
46. WHITMER JT, 1987. L-Carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res 61: 396-408.
47. YAMASHITA T, KOBAYASHI A, YAMAZAKI N, MIURA K, SHIRASAWA H, 1986. Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6. Cardiovasc Res 20: 614-620.